Takeda has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2, and -3, for the…
Vertex Pharmaceuticals (Nasdaq: VRTX) has received approval from the European Commission for the expansion of KALYDECO® (ivacaftor) labeling. This approval allows for the treatment of infants as young as 1 month old with cystic fibrosis (CF) who possess specific mutations…
Today, Pfizer Inc. (NYSE: PFE) announced the approval of BEQVEZ™ (fidanacogene elaparvovec-dzkt) by the U.S. Food and Drug Administration (FDA) for the treatment of adults grappling with moderate to severe hemophilia B. This approval is particularly significant for individuals currently…
The American Thoracic Society (ATS) International Conference, scheduled from May 17-22 in San Diego, will host the unveiling of twenty-five abstracts featuring both approved and investigational medicines from Sanofi. Among the highlights are presentations on Dupixent® (dupilumab), developed in collaboration…
Bristol Myers Squibb (NYSE: BMY) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of Opdivo® (nivolumab) combined with cisplatin and gemcitabine as the first-line treatment for…
Moderna, Inc. (NASDAQ: MRNA) and OpenAI have announced a collaborative effort aimed at harnessing the potential of artificial intelligence (AI) to revolutionize both business and healthcare. Moderna, known for its digital-first approach and early adoption of machine learning, is poised…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the production of Vertex’s cell therapies tailored for treating type 1…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the production of Vertex’s cell therapies tailored for treating type 1…
Roche Reports 2% Growth in Group Sales Despite Currency Impact In the first quarter of 2024, Roche saw a 2% increase in group sales at constant exchange rates (CER), though a 6% decrease was observed in Swiss francs (CHF) due…
Voydeya (danicopan) Receives EU Approval as Supplemental Treatment for Adults with PNH and Residual Hemolytic Anemia Voydeya (danicopan) has gained approval in the European Union (EU) to be used alongside ravulizumab or eculizumab for managing adult patients with paroxysmal nocturnal…
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), is extending an invitation to consumers to participate in future campaigns featuring their flagship brands, such as BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, their loyalty rewards program. Starting today,…
When a patient chooses a medication crafted by Orion, they can trust they’re receiving precisely the indicated dosage of active ingredients,” highlights Tomi Pitkäniemi, Automation Manager, underlining the critical role of his team’s efforts. Pitkäniemi heads the Design and Development…